2013-02-18 07:02:51 -
Oslo, Norway, 18 February 2013 - Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, will announce its fourth
quarter and full year 2012 results on Thursday, 28 February 2013. A presentation
by Algeta's senior management team to investors, analysts and the press will
take place in Oslo at 10:00 CET.
The presentation will also be webcast live and can be accessed through
www.algeta.com where questions can also be submitted during the presentation.
The presentation will take place at 10:00 CET at:
Shippingklubben
Haakon VIIs gate 1
0161 Oslo
Norway.
Algeta's senior management will also host an international conference call at
14:30 CET/08:30 Eastern Time (US) (details below).
To participate in the conference call, please dial the appropriate number below
five minutes prior to the
call:
US: +1 877 423 0830
UK: +44 20 7153 9154
Norway: +47 21 06 61 13
Sweden: +46 8-506 443 86
Denmark: +45 32 71 42 62
Switzerland: +41 44 580 65 22
Participant pin code: 434633#
To access the replay, please dial:
US: +1 877 679 2989
UK: +44 20 3364 5196
Norway: +47 23 50 02 03
Sweden: +46 8-505 564 73
Conference reference: 345360#
A replay version of the conference call will also be available at
www.algeta.com.
The results report and the presentation will be available at www.algeta.com in
the Investors section from 07:00 CET.
###
For further information, please contact:
Mike Booth / Renate Birkeli +47 23 00 67 32
Communications & Corporate Affairs
ir@algeta.com
Media enquiries:
Mark Swallow +44 207 638 9571
Citigate Dewe Rogerson
mark.swallow@citigatedr.co.uk
Knut Ekern +47 22 04 82 00
Gambit Hill & Knowlton
knut.ekern@hkstrategies.com
Kari Watson +1 781 235 3060
MacDougall Biomedical Communications
kwatson@macbiocom.com
US investor enquiries:
Tricia Swanson +1 646 378 2953
The Trout Group
tswanson@troutgroup.com
About Algeta
Algeta is a company focused on developing novel targeted therapies for patients
with cancer based on its alpha-pharmaceutical platform. The Company is
headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in
Cambridge, MA performing commercial marketing operations in the US. Algeta is
listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please
visit www.algeta.com.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Press release:
hugin.info/134655/R/1678622/547938.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE
[HUG#1678622]
